scispace - formally typeset
G

Graham Neale

Researcher at Imperial College London

Publications -  30
Citations -  3241

Graham Neale is an academic researcher from Imperial College London. The author has contributed to research in topics: Health care & Patient safety. The author has an hindex of 17, co-authored 30 publications receiving 3112 citations. Previous affiliations of Graham Neale include University College London.

Papers
More filters
Journal ArticleDOI

Adverse events in british hospitals: preliminary retrospective record review

TL;DR: These results suggest that adverse events are a serious source of harm to patients and a large drain on NHS resources.
Journal ArticleDOI

Preventable deaths due to problems in care in English acute hospitals: a retrospective case record review study

TL;DR: The incidence of preventable hospital deaths is much lower than previous estimates and a focus on deaths may not be the most efficient approach to identify opportunities for improvement given the low proportion of deaths due to problems with healthcare.
Journal ArticleDOI

Exploring the causes of adverse events in NHS hospital practice.

TL;DR: The underlying causes of errors in clinical practice are examined, rather than identifying specific errors made by individuals, to look at possible faults in the organization of care.
Journal ArticleDOI

Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place

TL;DR: It is suggested that incident reporting does not provide an adequate assessment of clinical adverse events and that this method needs to be supplemented with other more systematic forms of data collection.
Journal ArticleDOI

Case record review of adverse events: a new approach

TL;DR: The existing clinical review form (RF2) used in previous retrospective case record review studies is redesigned in order to clarify the review process and provide a more powerful analysis of adverse events; and then to ask clinicians to pilot and evaluate the new modular reviewform (MRF2).